R-116010

Overview

R-116010 is a potent and selective retinoic acid ( RA ) metabolism inhibitor and can inhibit hydroxylase CYP26 . R-116010 can enhance the anti-tumor effect of retinoic acid drugs. R-116010 can be used for the research of cancer , metabolic and neurological disease , such as neuroblastoma.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > RAR/RXR | Products > Signaling Pathways > Cytochrome P450

Product Information

• Catalog No.: HY-121500
• CAS No.: 355860-40-1
• Molecular Formula: C21H23N5S
• Molecular Weight: 377.51
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source